Inclusion completed

A phase I/IIa study of UV1 vaccination in patients with hormone-sensitive metastatic prostate cancer

Cancer type: Prostate cancer

Phase: I/II

Principal Investigator: Lilleby Wolfgang

Country: NO

Keywords: Norway, Oslo, UV1, Vaccine, Prostate

Status: Inclusion completed

Link to Clinicaltrials.gov: http://clinicaltrials.gov/ct2/show/NCT01784913?term=UV1&rank=1